A clinical random trial examining the effects of Avidekel oil on dystonia and spasticity in children who suffer from cerebral palsy or genetic impairment. Most participants reported significant improvement in spasticity and dystonia, sleep difficulties, pain severity, and quality of life.

KEY RESULTS:

• CBD-enriched 5% cannabis oil with CBD:THC ratios of 6:1 and 20:1 are effective in reducing the severity of dystonia and spasticity, and improving motor function ability and quality of life
  
• All patients demonstrated mood and appetite improvement
  
• Patients treated with the 6:1 ratio oil demonstrated sleep improvement
• Patients treated with the 20:1 ratio oil demonstrated improvement in constipation

STRAINS: Avidekel tested at 6:1 and 20:1 (CBD:THC) ratios

STUDY POPULATION:
20 patients with complex motor disorders (primarily cerebral palsy)